About: Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.30 (-4.17%)
NERV NASDAQ Minerva Neurosciences Inc
Minerva Neurosciences Inc share price
Atividade de preço de NERV
Último preço
$ 2,330
Variação (24h)
-0,07 USD (2,92%)
Volume
137.59K
Volume (média 4 sem.)
-
Abertura
$ 2,37
Variação do dia
$ 2,25 - $ 2,65
Fechamento anterior
$ 2,40
Último negócio
23 Oct, 8:00 pm GMT+0
Atrasado
23 Oct, 8:00 pm GMT+0
NERV price performance
Atrasado
23 Oct, 8:00 pm GMT+0
quote.marketSignals